• Ostatnia zmiana 14.09.2018 przez Zakład Analizy i Bioanalizy Leków

    Publikacje

     

    • Toloczko-Iwaniuk N, Dziemianczyk-Pakiela D, Nowaszewska BK, Celinska-Janowicz K, Miltyk W. Celecoxib in Cancer Therapy and Prevention - Review. Curr Drug Targets. 2018 Aug 3. doi: 10.2174/1389450119666180803121737.
    • Celińska-Janowicz K, Zaręba I, Lazarek U, Teul J, Tomczyk M, Pałka J, Miltyk W. Constituents of Propolis: Chrysin, Caffeic Acid, p-Coumaric Acid, and Ferulic Acid Induce PRODH/POX-Dependent Apoptosis in Human Tongue Squamous Cell Carcinoma Cell (CAL-27). Front Pharmacol. 2018 Apr 6;9:336. doi: 10.3389/fphar.2018.00336.
    • Zareba I, Celinska-Janowicz K, Surazynski A, Miltyk W, Palka J. Proline oxidase silencing induces proline-dependent pro-survival pathways in MCF-7 cells. Oncotarget. 2018 Feb 9;9(17):13748-13757. doi: 10.18632/oncotarget.24466.
    • Zareba I, Surazynski A, Chrusciel M, Miltyk W, Doroszko M, Rahman N, Palka J. Functional Consequences of Intracellular Proline Levels Manipulation Affecting PRODH/POX-Dependent Pro-Apoptotic Pathways in a Novel in Vitro Cell Culture Model. Cell Physiol Biochem. 2017;43(2):670-684. doi: 10.1159/000480653.
    • Siemionow K, Teul J, Drągowski P, Pałka J, Miltyk W. New potential biomarkers of acetaminophen-induced hepatotoxicity. Adv Med Sci. 2016 Sep;61(2):325-330. doi: 10.1016/j.advms.2016.05.001.
    • Czyżewska U, Siemionow K, Zaręba I, Miltyk W. Proapoptotic Activity of Propolis and Their Components on Human Tongue Squamous Cell Carcinoma Cell Line (CAL-27). PLoS One. 2016 Jun 9;11(6):e0157091. doi: 10.1371/journal.pone.0157091.
    • Moczydlowska J, Miltyk W, Hermanowicz A, Lebensztejn DM, Palka JA, Debek W. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats. J Invest Surg. 2017 Feb;30(1):41-46. doi: 10.1080/08941939.2016.1183734. Epub 2016 Jun 3.
    • Donejko M, Przylipiak A, Rysiak E, Miltyk W, Galicka E, Przylipiak J, Zaręba I, Surazynski A. Hyaluronic acid abrogates ethanol-dependent inhibition of collagen biosynthesis in cultured human fibroblasts. Drug Des Devel Ther. 2015 Nov 24;9:6225-33. doi: 10.2147/DDDT.S91968.
    • Kononczuk J, Czyzewska U, Moczydlowska J, Surażyński A, Palka J, Miltyk W. Proline Oxidase (POX) as A Target for Cancer Therapy. Curr Drug Targets. 2015;16(13):1464-9.
    • Czyżewska U, Konończuk J, Teul J, Drągowski P, Pawlak-Morka R, Surażyński A, Miltyk W. Verification of chemical composition of commercially available propolis extracts by gas chromatography-mass spectrometry analysis. J Med Food. 2015 May;18(5):584-91. doi: 10.1089/jmf.2014.0069.
    • Kononczuk J, Surazynski A, Czyzewska U, Prokop I, Tomczyk M, Palka J, Miltyk W. αIIbβ3-integrin Ligands: Abciximab and Eptifibatide as Proapoptotic Factors in MCF-7 Human Breast Cancer Cells. Curr Drug Targets. 2015;16(13):1429-37.
    • Mazurek-Wadołkowska E, Winnicka K, Czajkowska-Kośnik A, Czyzewska U, Miltyk W. Application of differential scanning calorimetry in evaluation of solid state interactions in tablets containing acetaminophen. Acta Pol Pharm. 2013 Sep-Oct;70(5):787-93.
    • Sadowska A, Prokopiuk S, Miltyk W, Surażyński A, Konończuk J, Sawicka D, Car H. Metronidazole affects breast cancer cell lines. Adv Med Sci. 2013;58(1):90-5. doi: 10.2478/v10039-012-0070-2.
    • Surazynski A, Miltyk W, Wolczynski S, Palka J. The effect of prolactin and estrogen cross-talk on prolidase- dependent signaling in MCF-7 cells. Neoplasma. 2013;60(4):355-63. doi: 10.4149/neo_2013_047.
    • Surazynski A, Miltyk W, Prokop I, Palka J. The effect of estrogen on prolidase-dependent regulation of HIF-1α expression in breast cancer cells. Mol Cell Biochem. 2013 Jul;379(1-2):29-36. doi: 10.1007/s11010-013-1623-9.
    • Surazynski A, Miltyk W, Prokop I, Palka J. Prolidase-dependent regulation of TGF β (corrected) and TGF β receptor expressions in human skin fibroblasts. Eur J Pharmacol. 2010 Dec 15;649(1-3):115-9. doi: 10.1016/j.ejphar.2010.09.034.
    • Rupérez F.J., Ramos-Mozo P., Teul J., Martinez-Pinna R., Garcia A., Malet-Martino M., Camafeita E., Lopez J.A., Pastor-Vargas C., Egido J., Balayssac S., Gilard V., Barbas C., Martin-Ventura J.L.: Metabolomic study of plasma of patients with abdominal aortic aneurysm. Anal Bioanal Chem. 2012. 403(6). 1651-1660.
    • Ciborowski M., Teul J., Martin-Ventura J.L., Egido J., Barbas C.: Metabolomics with LC-QTOF-MS Permits the Prediction of Disease Stage in Aortic Abdominal Aneurysm Based on Plasma Metabolic Fingerprint. PLoS ONE. 2012. 7(2). e31982. doi: 10.1371 /journal.pone.0031982
    • Teul J., Garcia A., Tuñón J., Martin-Ventura J.L., Tarín N., Bescós L.L., Egido J., Barbas C., Rupérez F.J.: Targeted and non-targeted metabolic time trajectory in plasma of patients after acute coronary syndrome. J Pharm Biomed Anal. 2011. Sep 10;56(2). 343-351.
    • Miltyk W, Surazynski A, Dondziło J, Palka J. 4'-chlorodiazepam--agonist ofperipheral benzodiazepine receptors as a protecting factor in IL-1 induced deregulation of collagen biosynthesis in cultured human chondrocytes. Eur J Pharmacol. 2010, 25;647(1-3):31-6.
    • Surazynski A, Miltyk W, Prokop I, Palka J. Prolidase-dependent regulation of TGF c and TGF β receptor expressions in human skin fibroblasts. Eur J Pharmacol. 2010, 15;649(1-3):115-9.
    • Markowska A, Bruzgo I, Miltyk W, Midura-Nowaczek K. Synthesis and activity of N-sulfonylamides of tripeptides as potential urokinase inhibitors. Protein Pept Lett. 2010; 17(10):1300-4.
    • Winnicka K, Bielawski K, Bielawska A, Miltyk W. Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts. Nat Prod Res. 2010; 24(3):274-85.
    • Teul J, Rupérez FJ, Garcia A, Vaysse J, Balayssac S, Gilard V, Malet-Martino M, Martin-Ventura JL, Blanco-Colio LM, Tuñón J, Egido J, Barbas C. Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints. J Proteome Res. 2009; 8(12):5580-9.
    • Miltyk W, Surazyński A, Sławomir W, Pałka JA. Combined therapy with disintegrin and melphalan as a new strategy in inhibition of endometrial cancer cell line (Ishikawa) growth. Folia Histochem Cytobiol. 2009; 47(5):S121-5.
    • Leśniewska M, Miltyk W, Swiatecka J, Tomaszewska M, Kuźmicki M, Pałka J, Wołczyński S. Estrogen receptor beta participate in the regulation of metabolizm of extracellular matrix in estrogen alpha negative breast cancer. Folia Histochem Cytobiol. 2009; 47(5):S107-12.
    • Stankiewicz-Kranc A, Miltyk W, Skrzydlewska E. Comparison of influence of carmustine and new proline analog of nitrosourea on antioxidant system in breast carcinoma cells (MCF-7). Drug Chem Toxicol. 2010; 33(1):55-63.
    • Kociecka B, Surazynski A, Miltyk W, Palka J. The effect of Telmisartan on collagen biosynthesis depends on the status of estrogen activation in breast cancer cells. Eur J Pharmacol. 2010; 628(1-3):51-6.
    • Surazynski A, Jarzabek K, Miltyk W, Wolczynski S, Palka J. Estrogen-dependent regulation of PPAR-gamma signaling on collagen biosynthesis in adenocarcinoma endometrial cells. Neoplasma. 2009; 56(5):448-54.
    • Surazynski A, Miltyk W, Czarnomysy R, Grabowska J, Palka J. Hyaluronic acid abrogates nitric oxide-dependent stimulation of collagen degradation in cultured human chondrocytes. Pharmacol Res. 2009; 60(1):46-9.